JP2017523810A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017523810A5 JP2017523810A5 JP2017526770A JP2017526770A JP2017523810A5 JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5 JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- dna
- mutant allele
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108700028369 Alleles Proteins 0.000 claims 22
- 238000000034 method Methods 0.000 claims 20
- 108020004414 DNA Proteins 0.000 claims 18
- 239000000523 sample Substances 0.000 claims 18
- 230000000903 blocking effect Effects 0.000 claims 11
- 238000002844 melting Methods 0.000 claims 11
- 230000008018 melting Effects 0.000 claims 11
- 238000003752 polymerase chain reaction Methods 0.000 claims 11
- 201000011510 cancer Diseases 0.000 claims 10
- 230000035772 mutation Effects 0.000 claims 10
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 claims 6
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 239000002157 polynucleotide Substances 0.000 claims 6
- 102000053602 DNA Human genes 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 5
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- 238000004458 analytical method Methods 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 239000010452 phosphate Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 230000006820 DNA synthesis Effects 0.000 claims 1
- 230000004568 DNA-binding Effects 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 claims 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462034231P | 2014-08-07 | 2014-08-07 | |
| US62/034,231 | 2014-08-07 | ||
| PCT/GR2015/000036 WO2016020710A1 (en) | 2014-08-07 | 2015-07-28 | Method of determining pik3ca mutational status in a sample |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017523810A JP2017523810A (ja) | 2017-08-24 |
| JP2017523810A5 true JP2017523810A5 (OSRAM) | 2018-06-21 |
| JP6770957B2 JP6770957B2 (ja) | 2020-10-21 |
Family
ID=53938365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017526770A Active JP6770957B2 (ja) | 2014-08-07 | 2015-07-28 | 試料中のｐｉｋ３ｃａ突然変異状態を決定する方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11279979B2 (OSRAM) |
| EP (1) | EP3198026B1 (OSRAM) |
| JP (1) | JP6770957B2 (OSRAM) |
| CN (1) | CN106715723B (OSRAM) |
| CA (1) | CA2957396C (OSRAM) |
| CY (1) | CY1122647T1 (OSRAM) |
| DK (1) | DK3198026T3 (OSRAM) |
| ES (1) | ES2764423T3 (OSRAM) |
| HR (1) | HRP20192353T1 (OSRAM) |
| HU (1) | HUE047958T2 (OSRAM) |
| IL (1) | IL250392B (OSRAM) |
| LT (1) | LT3198026T (OSRAM) |
| PL (1) | PL3198026T3 (OSRAM) |
| PT (1) | PT3198026T (OSRAM) |
| RS (1) | RS59710B1 (OSRAM) |
| SI (1) | SI3198026T1 (OSRAM) |
| SM (1) | SMT202000005T1 (OSRAM) |
| WO (1) | WO2016020710A1 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102017898B1 (ko) | 2010-05-14 | 2019-09-04 | 더 제너럴 하스피톨 코포레이션 | 종양 특이적 신생항원을 확인하는 조성물 및 방법 |
| WO2015039024A1 (en) | 2013-09-16 | 2015-03-19 | Oregon Health & Science University | Bioabsorbable clips and applicator for tissue closure |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| EP3082853A2 (en) | 2013-12-20 | 2016-10-26 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
| ES2864278T3 (es) | 2014-11-03 | 2021-10-13 | Univ Oregon Health & Science | Clips y aplicador para cierre de tejidos |
| ES3049406T3 (en) | 2014-12-19 | 2025-12-16 | Broad Inst Inc | Methods for profiling the t-cell-receptor repertoire |
| EP3234193B1 (en) | 2014-12-19 | 2020-07-15 | Massachusetts Institute of Technology | Molecular biomarkers for cancer immunotherapy |
| CN108025048B (zh) | 2015-05-20 | 2022-10-25 | 博德研究所 | 共有的新抗原 |
| EP3358020B1 (en) * | 2017-01-05 | 2021-05-19 | Biodesix, Inc. | Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood |
| US11549149B2 (en) | 2017-01-24 | 2023-01-10 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| EP3606550A2 (en) | 2017-04-03 | 2020-02-12 | Neon Therapeutics, Inc. | Protein antigens and uses thereof |
| CN107287309A (zh) * | 2017-07-06 | 2017-10-24 | 罗保君 | 一种血液循环肿瘤dna点突变检测方法 |
| EP3660168A4 (en) * | 2017-07-26 | 2021-04-21 | Sekisui Medical Co., Ltd. | METHOD OF DETECTING MUTUAL GENES |
| CN109306374A (zh) * | 2017-09-08 | 2019-02-05 | 广州健天基因技术有限公司 | 用于检测人类pik3ca基因e545k突变的引物、检测方法及试剂盒 |
| CN109295175A (zh) * | 2017-09-08 | 2019-02-01 | 广州健天基因技术有限公司 | 用于检测人胃肠道间质瘤c-kit基因v559a突变的引物、检测方法及试剂盒 |
| JP7306618B2 (ja) * | 2017-09-26 | 2023-07-11 | 東ソー株式会社 | がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法 |
| US11793867B2 (en) | 2017-12-18 | 2023-10-24 | Biontech Us Inc. | Neoantigens and uses thereof |
| CN107937490A (zh) * | 2018-01-15 | 2018-04-20 | 福建农林大学 | 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒 |
| JP2021513342A (ja) * | 2018-02-12 | 2021-05-27 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 腫瘍の遺伝的不均一性を評価することによって治療法に対する応答を予測する方法 |
| US12246067B2 (en) | 2018-06-19 | 2025-03-11 | Biontech Us Inc. | Neoantigens and uses thereof |
| CN109666747A (zh) * | 2019-02-20 | 2019-04-23 | 天津脉络医学检验有限公司 | 一种引物探针组合物及其应用 |
| US11812966B2 (en) | 2020-04-24 | 2023-11-14 | NeuraMedica Inc. | Clips, appliers, and cartridges |
| CN113930500B (zh) * | 2020-07-13 | 2024-11-19 | 铭炽生物科技(上海)有限公司 | 人pik3ca基因突变的数字pcr检测方法及应用 |
| CN112951325B (zh) * | 2021-02-18 | 2023-04-21 | 北京吉因加医学检验实验室有限公司 | 一种用于癌症检测的探针组合的设计方法及其应用 |
| CN113063835B (zh) * | 2021-03-19 | 2022-08-02 | 中山大学 | 一种基于元素标记-电感耦合等离子体质谱检测策略的cfDNA分析方法及其应用 |
| WO2023025218A1 (zh) * | 2021-08-25 | 2023-03-02 | 南京金斯瑞生物科技有限公司 | 一种用于检测单碱基突变的引物组和基因芯片方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2437590T3 (es) * | 2004-03-02 | 2014-01-13 | The Johns-Hopkins University | Mutaciones del gen de PIK3CA en cánceres humanos |
| SG10201506658TA (en) * | 2007-02-26 | 2015-09-29 | Wayne John Cancer Inst | Utility of b-raf dna mutation in diagnosis and treatment of cancer |
| US8071338B2 (en) * | 2007-08-08 | 2011-12-06 | Roche Molecular Systems, Inc. | Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity |
| GB2453173A (en) | 2007-09-28 | 2009-04-01 | Dxs Ltd | Polynucleotide primers |
| US20100041048A1 (en) * | 2008-07-31 | 2010-02-18 | The Johns Hopkins University | Circulating Mutant DNA to Assess Tumor Dynamics |
| CN101445832B (zh) * | 2008-12-23 | 2011-09-14 | 广州益善生物技术有限公司 | Pik3ca基因突变的检测探针、液相芯片及其检测方法 |
| CN102234685B (zh) * | 2010-04-23 | 2014-08-27 | 益善生物技术股份有限公司 | 一种pik3ca基因突变检测液相芯片 |
| EP2646576B1 (en) | 2010-12-03 | 2015-10-28 | Brandeis University | Methods and kits for detecting nucleic acid mutants in wild-type populations |
| CN102533958A (zh) | 2010-12-28 | 2012-07-04 | 苏州科贝生物技术有限公司 | 一种检测人pik3ca基因突变的方法和试剂盒 |
| WO2012095378A1 (en) * | 2011-01-11 | 2012-07-19 | Roche Diagnostics Gmbh | High resolution melting analysis as a prescreening tool |
| WO2012131092A2 (en) * | 2011-03-31 | 2012-10-04 | Signature Diagnostics Ag | Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages |
| CN103635593B (zh) * | 2011-05-04 | 2018-03-20 | 生物概念股份有限公司 | 用于检测核酸序列变体的方法 |
| AU2012296385A1 (en) | 2011-08-18 | 2014-02-20 | Nestec S.A. | Compositions and methods for detecting allelic variants |
| JP2013081450A (ja) * | 2011-09-27 | 2013-05-09 | Arkray Inc | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット |
| US11261494B2 (en) * | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| EP2711432A1 (en) * | 2012-09-21 | 2014-03-26 | Genomica S.A.U. | Method for detection of BRAF and PI3K mutations |
| CN105378160B (zh) * | 2013-08-12 | 2018-04-17 | 伯乐生命医学产品有限公司 | 具有碱基配对的寡聚体的扩增报告子 |
-
2015
- 2015-07-28 WO PCT/GR2015/000036 patent/WO2016020710A1/en not_active Ceased
- 2015-07-28 LT LTEP15753745.7T patent/LT3198026T/lt unknown
- 2015-07-28 SI SI201531052T patent/SI3198026T1/sl unknown
- 2015-07-28 RS RS20191668A patent/RS59710B1/sr unknown
- 2015-07-28 PT PT157537457T patent/PT3198026T/pt unknown
- 2015-07-28 DK DK15753745.7T patent/DK3198026T3/da active
- 2015-07-28 HR HRP20192353TT patent/HRP20192353T1/hr unknown
- 2015-07-28 JP JP2017526770A patent/JP6770957B2/ja active Active
- 2015-07-28 ES ES15753745T patent/ES2764423T3/es active Active
- 2015-07-28 HU HUE15753745A patent/HUE047958T2/hu unknown
- 2015-07-28 US US15/501,457 patent/US11279979B2/en active Active
- 2015-07-28 SM SM20200005T patent/SMT202000005T1/it unknown
- 2015-07-28 EP EP15753745.7A patent/EP3198026B1/en active Active
- 2015-07-28 PL PL15753745T patent/PL3198026T3/pl unknown
- 2015-07-28 CA CA2957396A patent/CA2957396C/en active Active
- 2015-07-28 CN CN201580052321.9A patent/CN106715723B/zh active Active
-
2017
- 2017-02-01 IL IL250392A patent/IL250392B/en active IP Right Grant
-
2019
- 2019-12-30 CY CY20191101363T patent/CY1122647T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017523810A5 (OSRAM) | ||
| HRP20192353T1 (hr) | Metoda određivanja mutacijskog statusa pik3ca u uzorku | |
| US12270081B2 (en) | Method for quantification of PD-L1 expression | |
| Miotke et al. | High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR | |
| ES2577289T3 (es) | Calreticulina mutante para el diagnóstico de malignidades mieloides | |
| JP2017525371A5 (OSRAM) | ||
| Cabanero et al. | Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer | |
| JP2012525147A5 (OSRAM) | ||
| JP2019518437A (ja) | 多重／最適化ミスマッチ増幅（ｍｏｍａ）−がんの評価のためのリアルタイムｐｃｒ | |
| Gonzalez-Bosquet et al. | Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers | |
| JP7085235B2 (ja) | 膵がん診断キット | |
| Jin et al. | Rapid and accurate detection of KRAS mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics | |
| Zeng et al. | Detection of PIK3CA mutations in plasma DNA of colorectal cancer patients by an ultra-sensitive PNA-mediated PCR | |
| Tabone et al. | Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study | |
| JP2015500638A5 (OSRAM) | ||
| JP2020019738A (ja) | がんの診断のためのプローブ／プライマーライブラリー | |
| JPWO2019045016A1 (ja) | 高感度かつ定量的な遺伝子検査方法、プライマーセット、及び検査キット | |
| JP4968577B2 (ja) | サイトケラチン１９（ＣＫ１９）ｍＲＮＡの迅速測定法、並びにそのためのプライマー及びプローブ | |
| KR102600344B1 (ko) | Kras 유전자 돌연변이 검출용 조성물 및 이를 포함하는 키트 | |
| Feuillie et al. | Detection of DNA sequences refractory to PCR amplification using a biophysical SERRS assay (Surface Enhanced Resonant Raman Spectroscopy) | |
| US12391985B2 (en) | Method of determining PIK3CA mutational status in a sample | |
| JP2014535050A5 (OSRAM) | ||
| WO2014078571A1 (en) | Methods of detecting 14q32 translocations | |
| JP6346493B2 (ja) | ペプチドワクチン療法の効果予測方法 | |
| KR101598327B1 (ko) | Dna 복제수 변이를 이용한 강직성 척추염 발병 위험도 예측용 조성물 및 이를 이용한 예측 방법 |